Our findings suggest that the increase in PRMT1 expression in liver in obesity serves as a compensatory mechanism for the decrease in SAM to alleviate HFD-induced hepatic steatosis and liver damage by promoting fatty acid oxidation. This evidence concerns the gene PRMT1 and obesity due to melanocortin 4 receptor deficiency.